203 related articles for article (PubMed ID: 31523182)
1. Combined Aberrant Expression of NDRG2 and LDHA Predicts Hepatocellular Carcinoma Prognosis and Mediates the Anti-tumor Effect of Gemcitabine.
Guo Y; Li X; Sun X; Wang J; Yang X; Zhou X; Liu X; Liu W; Yuan J; Yao L; Li X; Shen L
Int J Biol Sci; 2019; 15(9):1771-1786. PubMed ID: 31523182
[TBL] [Abstract][Full Text] [Related]
2. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.
Zheng J; Li Y; Yang J; Liu Q; Shi M; Zhang R; Shi H; Ren Q; Ma J; Guo H; Tao Y; Xue Y; Jiang N; Yao L; Liu W
BMC Cancer; 2011 Jun; 11():251:1-9. PubMed ID: 21676268
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathway.
Guo Y; Ma J; Wu L; Wang Q; Li X; Li X; Zhang Y; Zhang J; Yao L; Zhang J; Liu W
PLoS One; 2013; 8(4):e61079. PubMed ID: 23630579
[TBL] [Abstract][Full Text] [Related]
5. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
[TBL] [Abstract][Full Text] [Related]
6. The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway.
Wang J; Yin D; Xie C; Zheng T; Liang Y; Hong X; Lu Z; Song X; Song R; Yang H; Sun B; Bhatta N; Meng X; Pan S; Jiang H; Liu L
Oncotarget; 2014 Sep; 5(18):8478-91. PubMed ID: 25261367
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect.
Woodford MR; Baker-Williams AJ; Sager RA; Backe SJ; Blanden AR; Hashmi F; Kancherla P; Gori A; Loiselle DR; Castelli M; Serapian SA; Colombo G; Haystead TA; Jensen SM; Stetler-Stevenson WG; Loh SN; Schmidt LS; Linehan WM; Bah A; Bourboulia D; Bratslavsky G; Mollapour M
Nat Struct Mol Biol; 2021 Aug; 28(8):662-670. PubMed ID: 34381247
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Lactate Dehydrogenase-A Impairs Oncogene-Induced Mouse Hepatocellular Carcinoma Development.
Serra M; Di Matteo M; Serneels J; Pal R; Cafarello ST; Lanza M; Sanchez-Martin C; Evert M; Castegna A; Calvisi DF; Mazzone M; Columbano A
Cell Mol Gastroenterol Hepatol; 2022; 14(3):609-624. PubMed ID: 35714859
[TBL] [Abstract][Full Text] [Related]
10. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
12. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma.
Li A; Yan Q; Zhao X; Zhong J; Yang H; Feng Z; Du Y; Wang Y; Wang Z; Wang H; Zhou Y; Liu S; Nie Y
Oncotarget; 2016 Jan; 7(1):524-37. PubMed ID: 26594798
[TBL] [Abstract][Full Text] [Related]
14. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
[TBL] [Abstract][Full Text] [Related]
15. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer.
Lin J; Zhong W; Lyu Z; Peng J; Rong Y; Zeng K; Lai J; Wu D; Wang J; Li Y; Zheng J; Zhang J; Pan Z
Cancer Lett; 2024 May; 589():216825. PubMed ID: 38548218
[TBL] [Abstract][Full Text] [Related]
17. miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA.
Hua S; Liu C; Liu L; Wu D
Biochem Biophys Res Commun; 2018 Feb; 496(3):947-954. PubMed ID: 29360449
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation of NDRG2 in gastric cancer and its clinical significance.
Chang X; Li Z; Ma J; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Dig Dis Sci; 2013 Mar; 58(3):715-23. PubMed ID: 23010743
[TBL] [Abstract][Full Text] [Related]
19. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
20. Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.
Wu Q; Wang X; Liu J; Zheng J; Liu Y; Li Y; Su F; Ou W; Wang R
Oncol Rep; 2016 Sep; 36(3):1325-32. PubMed ID: 27430152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
